Journal Flyer

Advances in Cancer Research & Clinical Imaging - ACRCI

ISSN: 2688-8203

Managing Editor: Julia Vinscent

Contact us at:

Open Access Mini Review

Benefits of Losartan in the Presence of Ovarian Cáncer

Mirta D Ambra*

University Buenos Aires and Member World Virology Society, Argentina

Corresponding Author

Received Date: November 25, 2019;  Published Date: December 03, 2019

Abstract

Losartan is an antihypertensive drug that acts on the tumor extracellular matrix. Its use can improve the arrival and action of chemotherapists in the presence of ovarian cáncer.

Article Details
Citation

  • Mirta D Ambra. Benefits of Losartan in the Presence of Ovarian Cáncer. Adv Can Res & Clinical Imag. 2(3): 2019. ACRCI. MS.ID..000536.

Signup for Newsletter
  • newsletter-subscription
© 2018 Iris Publishers LLC, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use. Creative Commons License Open Access by
Iris Publishers LLC is licensed under Creative Commons License a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com. Best viewed in browser_icons browser_icons | Above IE 9.0 version | Privacy Policy
Scroll to Top